Physician profile
Angie Lee
NPI 1578298519
$3,753.92
in general payments reported to CMS, 2019-2025
23 companies · $3,485 in 2025
The $3,485 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $269 · 2025: $3,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,829 · Travel and Lodging: $889 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,829.27 |
| Travel and Lodging | $888.65 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,151.92 | 2025 | Urolift, Barrigel |
| Medtronic, INC. | $800.02 | 2025 | Interstim |
| Sumitomo Pharma America, INC. | $299.98 | 2024-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $266.73 | 2025 | Erleada |
| Calyxo, INC. | $220.33 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $177.72 | 2024-2025 | |
| Urogen Pharma, INC. | $147.81 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $128.89 | 2024-2025 | Prolaris |
| Sun Pharmaceutical Industries INC. | $123.07 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $99.14 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $83.90 | 2025 | Lynparza, Keytruda, Keytruda Qlex |
| Abbvie INC. | $39.13 | 2025 | |
| Endo USA, INC. | $37.23 | 2024-2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $25.78 | 2025 | Bard Urinary Drainage Bag |
| Immunitybio, INC. | $21.78 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $21.06 | 2024 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals Lp | $18.81 | 2025 | Lynparza |
| Laborie Medical Technologies Corp. | $17.77 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.06 | 2025 | Adstiladrin |
| Vertex Pharmaceuticals Incorporated | $15.60 | 2025 | |
| Sandoz INC. | $14.33 | 2025 | Jubbonti, Wyost |
| Tolmar, INC. | $13.82 | 2025 | Eligard, Jatenzo |
| Pharmaand Gmbh | $13.04 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.